Lee's Pharmaceutical Holdings Limited
LPCUF
$0.185
-$0.0091-4.69%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 11.92M | 9.99M | 8.06M | 5.10M | 2.13M |
| Total Depreciation and Amortization | 12.72M | 12.79M | 12.87M | 13.33M | 13.78M |
| Total Amortization of Deferred Charges | 6.22M | 5.76M | 5.31M | 5.31M | 5.31M |
| Total Other Non-Cash Items | 6.74M | 3.55M | 390.40K | 1.63M | 2.86M |
| Change in Net Operating Assets | -6.55M | -8.28M | -10.02M | -10.02M | -10.02M |
| Cash from Operations | 31.05M | 23.82M | 16.63M | 15.34M | 14.07M |
| Capital Expenditure | -5.64M | -4.50M | -3.37M | -3.57M | -3.76M |
| Sale of Property, Plant, and Equipment | 31.00K | 22.80K | 14.60K | 14.60K | 14.60K |
| Cash Acquisitions | -- | -1.00K | -2.00K | -2.00K | -2.00K |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -18.79M | -15.50M | -12.22M | -13.51M | -14.80M |
| Cash from Investing | -24.40M | -19.98M | -15.58M | -17.06M | -18.54M |
| Total Debt Issued | 183.92M | 144.18M | 104.45M | 104.45M | 104.45M |
| Total Debt Repaid | -168.21M | -124.31M | -80.41M | -80.41M | -80.41M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -2.27M | -1.81M | -1.36M | -1.35M | -1.35M |
| Other Financing Activities | 0.00 | 3.63M | 7.26M | 3.63M | 0.00 |
| Cash from Financing | -266.40K | 1.19M | 2.65M | 2.18M | 1.71M |
| Foreign Exchange rate Adjustments | -65.70K | -5.80K | 53.70K | 21.80K | -10.10K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 6.32M | 5.03M | 3.74M | 484.00K | -2.78M |